Want to see IN:ACUTAAS full AI Analyst Report?

Acutaas Chemicals (ACUTAAS) Price & Analysis

6 Followers

ACUTAAS Stock Chart & Stats

₹1747.20

-₹131.70(-5.63%)

At close: Jan 09 4:00 PM EST

₹1747.20

-₹131.70(-5.63%)

Day’s Range― - ―

52-Week Range₹1,290.05 - ₹3,735.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)30.37K

Market Cap

₹261.60B

Enterprise Value₹208.83K

Total Cash (Recent Filing)₹2.41B

Total Debt (Recent Filing)₹83.49M

Price to Earnings (P/E)67.8

Beta1.34

Next Earnings

Nov 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.08%

Share Statistics

EPS (TTM)33.38

Shares Outstanding81,871,124

10 Day Avg. Volume27,101

30 Day Avg. Volume30,368

Financial Highlights & Ratios

PEG Ratio0.91

Price to Book (P/B)7.73

Price to Sales (P/S)10.06

P/FCF Ratio-132.71

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)55.48

Revenue Forecast (FY)₹17.77B

Bulls Say, Bears Say

Bulls Say

Revenue And Margin ExpansionSharp FY2026 revenue acceleration alongside substantially higher net and EBIT margins indicates stronger operating leverage or product mix. If maintained, this combination can expand earnings capacity, support reinvestment, and strengthen Acutaas Chemicals’ competitive position over coming quarters.

Conservative Recent LeverageVery low recent leverage limits interest and refinancing pressure while preserving financial flexibility for investment or resilience during weaker conditions. The improvement in ROE also shows that the expanded equity base is generating stronger returns, supporting capital efficiency.

Improved Operating Cash GenerationThe substantial FY2026 improvement in operating cash flow and coverage of reported earnings suggests that recent profit growth was supported by cash generation, not only accounting income. This strengthens internal funding capacity, although continued reinvestment still needs monitoring.

Bears Say

Persistently Negative Free Cash FlowPersistent negative free cash flow indicates that operating cash has not covered capital investment or other reinvestment needs across the reported period. This can constrain internally funded growth, increase dependence on financing, and reduce flexibility even while accounting profits are strong.

Cash-Flow VolatilityA history that includes negative operating cash flow shows that cash conversion can vary materially across cycles or operating conditions. Even with the FY2026 rebound, this volatility makes earnings quality less predictable and complicates planning for investment, liquidity, and shareholder returns.

Margin And Earnings VolatilityThe wide swing in net margin demonstrates that profitability has not been consistently stable over the full period. Such sensitivity can make future earnings harder to forecast, weaken confidence in margin sustainability, and leave results more exposed if favorable operating conditions reverse.

Acutaas Chemicals News

Acutaas Chemicals Sets Record Date for 50% Final Dividend

Acutaas Chemicals ( ($IN:ACUTAAS) ) has issued an update. Acutaas Chemicals Limited has set 17 September 2026 as...

1M ago

Acutaas Chemicals Outlines TDS Rules on Proposed FY26 Final Dividend

Acutaas Chemicals ( ($IN:ACUTAAS) ) has provided an announcement. Acutaas Chemicals has informed shareholders that its board has...

1M ago

Acutaas opens South Korean semiconductor materials plant via Indichem

Acutaas Chemicals ( ($IN:ACUTAAS) ) has shared an announcement. Acutaas Chemicals has inaugurated a semiconductor materials plant in...

1M ago

Acutaas Chemicals Publishes AGM Notice to Meet SEBI Disclosure Rules

Acutaas Chemicals ( ($IN:ACUTAAS) ) just unveiled an update. Acutaas Chemicals Limited has notified exchanges that it has...

1M ago

Acutaas Chemicals Publishes Q1 FY26 Investor Presentation

Acutaas Chemicals ( ($IN:ACUTAAS) ) has provided an announcement. Acutaas Chemicals Limited has released an investor presentation detailing...

2M ago

Tax Authority Conducts Search at Acutaas Chemicals’ Surat Facilities

The latest update is out from Acutaas Chemicals ( ($IN:ACUTAAS) ). Acutaas Chemicals disclosed that the Central Goods...

3M ago

ACUTAAS FAQ

What was Acutaas Chemicals Ltd’s price range in the past 12 months?

Acutaas Chemicals Ltd lowest stock price was ₹1290.05 and its highest was ₹3735.00 in the past 12 months.

What is Acutaas Chemicals Ltd’s market cap?

Acutaas Chemicals Ltd’s market cap is ₹261.60B.

When is Acutaas Chemicals Ltd’s upcoming earnings report date?

Acutaas Chemicals Ltd’s upcoming earnings report date is Nov 14, 2026 which is in 42 days.

How were Acutaas Chemicals Ltd’s earnings last quarter?

Acutaas Chemicals Ltd released its earnings results on Jul 24, 2026. The company reported ₹9.1 earnings per share for the quarter, missing the consensus estimate of ₹9.35 by -₹0.25.

Is Acutaas Chemicals Ltd overvalued?

According to Wall Street analysts Acutaas Chemicals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Acutaas Chemicals Ltd pay dividends?

Acutaas Chemicals Ltd pays a Annually dividend of ₹2.5 which represents an annual dividend yield of 0.08%. See more information on Acutaas Chemicals Ltd dividends here

What is Acutaas Chemicals Ltd’s EPS estimate?

Acutaas Chemicals Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Acutaas Chemicals Ltd have?

Acutaas Chemicals Ltd has 81,871,124 shares outstanding.

What happened to Acutaas Chemicals Ltd’s price movement after its last earnings report?

Acutaas Chemicals Ltd reported an EPS of ₹9.1 in its last earnings report, missing expectations of ₹9.35. Following the earnings report the stock price went down -5.751%.

Which hedge fund is a major shareholder of Acutaas Chemicals Ltd?

Currently, no hedge funds are holding shares in IN:ACUTAAS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Acutaas Chemicals Ltd

Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.